These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24632340)

  • 1. Predictors and outcomes of "super-response" to cardiac resynchronization therapy.
    Killu AM; Grupper A; Friedman PA; Powell BD; Asirvatham SJ; Espinosa RE; Luria D; Rozen G; Buber J; Lee YH; Webster T; Brooke KL; Hodge DO; Wiste HJ; Glikson M; Cha YM
    J Card Fail; 2014 Jun; 20(6):379-86. PubMed ID: 24632340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival.
    Manne M; Rickard J; Varma N; Chung MK; Tchou P
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):970-7. PubMed ID: 23718783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of patients with and without super-response to CRT-D.
    Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
    Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential predictors of non-response and super-response to cardiac resynchronization therapy.
    Qiao Q; Ding LG; Hua W; Chen KP; Wang FZ; Zhang S
    Chin Med J (Engl); 2011 May; 124(9):1338-441. PubMed ID: 21740744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of super-response to cardiac resynchronization therapy.
    Rickard J; Kumbhani DJ; Popovic Z; Verhaert D; Manne M; Sraow D; Baranowski B; Martin DO; Lindsay BD; Grimm RA; Wilkoff BL; Tchou P
    Heart Rhythm; 2010 Jul; 7(7):885-9. PubMed ID: 20382271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.
    Brambatti M; Guerra F; Matassini MV; Cipolletta L; Barbarossa A; Urbinati A; Marchesini M; Capucci A
    Europace; 2013 May; 15(5):704-10. PubMed ID: 23385052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry.
    António N; Teixeira R; Coelho L; Lourenço C; Monteiro P; Ventura M; Cristóvão J; Elvas L; Gonçalves L; Providência LA
    Europace; 2009 Mar; 11(3):343-9. PubMed ID: 19240109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment.
    van der Heijden AC; Höke U; Thijssen J; Borleffs CJ; van Rees JB; van der Velde ET; Schalij MJ; van Erven L
    Eur J Heart Fail; 2014 Oct; 16(10):1104-11. PubMed ID: 25138313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy.
    Zecchin M; Proclemer A; Magnani S; Vitali-Serdoz L; Facchin D; Muser D; Nordio A; Barbati G; Puggia I; Sinagra G; Proclemer A
    Europace; 2014 Mar; 16(3):363-71. PubMed ID: 24189477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience.
    Frigerio M; Lunati M; Pasqualucci D; Vargiu S; Foti G; Pedretti S; Vittori C; Cattafi G; Magenta G; Campo C; Bisetti S; Mercuro G
    Int J Cardiol; 2014 Mar; 172(1):64-71. PubMed ID: 24456869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analyses of super-response to cardiac resynchronization therapy in patients with congestive heart failure: a multiple center trial].
    Wang DM; Qi SY; Yu HB; Ding C; Zang HY; Tian FL; Ru LS; Li J; Zhang B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):662-7. PubMed ID: 24225237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.